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DIALYSIS - TRANSPLANTATION
Calcium channel blockers correct in vitro mitochondrial toxicity
of cellulose acetate
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Calcium channel blockers correct in vitro mitochondrial toxicity of
cellulose acetate. We studied the action of rinse solutions from cellulose
acetate hemodialyzers on isolated mitochondria. We showed that concen-
trates from the rinses impaired the adenosine 5'-triphosphate (ATP)
synthesis as reflected by the decrease in respiration during state 3 and in
PlO ratio. This impairment results from a calcium release from mitochon-
dna that is induced by rinse solution concentrates. The release, triggering
the mitochondrial calcium carrier, would explain the decrease in ATP
synthesis. Moreover, rinse solution concentrates hinder mitochondrial
calcium storage. The rise in cytosolic calcium in hemodialyzed patients
may be related, at least in part, to these findings, since a lack of ATP
impairs the ATP-dependent cellular calcium-extrusion pumps. We also
showed that calcium channel blockers, at therapeutically relevant doses,
restore ATP synthesis and calcium storage in mitochondria impaired by
rinse solution concentrates. Finally, these in vitro results were confirmed
by experiments on cells in culture proving that Diltiazem counteracts the
cytotoxicity of rinse solution concentrates. These findings are consistent
with observations that these drugs suppress the increase in leukocyte
cytosolic calcium in dialyzed patients. Moreover, this would help explain
the efficiency of calcium channel blockers in cells without L-calcium
channels.
Many aspects of hemodialyzer biocompatibility depend on an
activation of complement [1, 2]. Besides this classical mechanism,
several reports have pointed to a blood cell activation that is
calcium dependent and complement independent. For example,
contact with cuprammonium membrane induces a rise in cytosolic
calcium in various cells [3]. Such a rise has been also demon-
strated in polymorphonuclear neutrophils from patients undergo-
ing hemodialysis with polymethylmethacrylate or cellulosic mem-
branes [4, 5]. In the same way degranulation of neutrophils by
cuprophane membrane is partially dependent on heat-stable
complement-independent plasma factors. The selective chelation
of Ca2 abolished the degranulating activity of these plasma-
borne factors [6]. Also, calcium ions might trigger granulocyte
activation [7].
The involvement of an increase in cytosolic calcium [(Ca2),1 in
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the activation of blood cells points to a possible beneficial effect of
calcium channel blockers (CCB). Several reports showed that
therapy with CCB can correct granulocyte activation [4, 5, 7—9]
and suppress the increase in (Ca2)1 in vivo [4, 5J. A question thus
arises: since CCB are efficient in cells such as neutrophils that do
not have L-type voltage dependent calcium channels, the classical
site of action for CCB [10, 111. The action mechanism of CCB in
this type of cells is thus not totally understood.
The increase in (Ca2)1 may be related to an impairment of
cellular calcium-exporting ATP-dependent pumps because of
their fundamental role in maintaining (Ca24) homeostasis [12].
As mitochondria are the main supplier of cellular ATP, this
suggests that they may be implicated in the calcium-dependent
mechanisms of biocompatibility. Such a hypothesis is supported
by our preliminary results [13] showing that aqueous rinses from
cellulosic hemodialyzers were toxic for cells in culture and im-
paired mitochondrial functions, particularly ATP synthesis. In a
previous report we showed that CCB can directly restore ATP
synthesis in isolated injured mitochondria [14]. Taken together,
these findings lead to the idea that CCB could suppress granulo-
cyte activation and the increase in (Ca2)1 not by inhibiting
L-channels but rather by a direct action on mitochondria.
The aim of the present paper was to study the action mecha-
nism of rinse solution concentrates from hemodialyzers fitted with
cellulose acetate on isolated mitochondria and to test the effect of
CCB on the so-injured mitochondria. We found that: (a) rinse
solution concentrates impaired mitochondrial functions, particu-
larly ATP synthesis, by a calcium dependent mechanism; (b) CCB
restore the ATP synthesis in these calcium-injured mitochondria;
(c) CCB counteract the toxicity of rinse solution concentrates on
cells in culture.
METHODS
Reagents
The sterile and apyrogenic water was purchased from Fresenius
laboratory, 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium
bromide (MTT). Dulbecco's medium and all the other reagents
were Sigma Chemical Co. products.
Rinse solution concentrates from hemodialyzers
We used Altra Nova 140 hemodialyzers fitted with cellulose
acetate membrane (Althin Medical Inc.) sterilized with ethylene
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oxide (ETO). We tried to operate under experimental conditions
as close as possible to clinical ones. We thus rinsed the hemodia-
lyzer that was ready for use twice by passing 2 liters of apyrogenic
and sterile water through the blood compartment of the dialyzers.
The rate of the rinse was 150 mi/mm at 20°C. The first single pass
rinse was then rejected and the second single pass was lyophilized.
The residue was redissolved in sterile and apyrogenic water and
relyophilized. The operation was then repeated. The final residue
was dissolved in 3 ml of apyrogenic and sterile water for the
mitochondrial study or in 3 ml of culture medium for the cellular
study. We thus obtained the so-called rinse solution concentrate
from the cellulose acetate hemodialyzer (RSCAH). Six Altra
Nova hemodialyzers corresponding to three different manufactur-
ing batches were used. For comparison we obtained rinse solution
concentrates from Polysulfone (Hemoflow F60, Fresenius) ETO
sterilized and cellulose acetate (Altra Nova 140, Aithin) sterilized
with y rays. As a control we obtained rinse solution concentrates
from blood lines ETO sterilized by three lyophilizations of the
initial 2 liters of rinse. A control was done by lyophilizing 2 liters
of sterile and apyrogenic water without passing the liquid through
the dialysis membrane.
The pH of all the concentrates and all the reagents was adjusted
to 7.2 before use in the mitochondrial and cellular studies.
Mitochondrial study
Preparation of mitochondria. Mitochondria were obtained from
rat livers by using a modified version [151 of the technique of
Johnson and Lardy. We used male Wistar rats (170 to 220 g) aged
less than three months. Mitochondrial protein was determined by
Biorad Assay (Bio-Rad Laboratories).
Respiration rate measurements. Oxygen consumption was mea-
sured in a water-jacketed reaction chamber (1.8 ml) at 25°C by
using a Clark microelectrode fitted to a Gilson oxygraph. Mito-
chondria (1.5 mg of protein) were suspended in respiratory
medium (sucrose 0.25 M, KH2PO4 4 mi, rotenone 1 /.LM, pH 7.2
adjusted with KOH). Sodium succinate was used as a substrate (6
m final concentration); oxidative phosphorylation was started by
adding ADP to reach a final concentration of 0.10 mrvi.
Oxygen consumption recordings (Fig. 1) measured: (1) V3, the
consumption rate during state 3 corresponding to the ATP
synthesis; (2) V4, the consumption rate during state 4 that was
reached when all ADP was phosphorylated into ATP. Rates were
expressed as nmoles oxygen consumed per mm and per mg of
mitochondrial protein. (3) The PlO ratio was measured, which
was calculated from oxygen consumption during state 3 and
corresponded to the number of ADP molecules added per oxygen
atom consumed. P/O represented the yield of ATP synthesis. (4)
Respiratory controls (RC) was defined as the ratio V3/V4. The
mitochondria exhibited RC values between 3.0 and 4.5. These
values were low because the respiratory medium did not contain
bovine serum albumin and EGTA in order not to modify the
calcium concentration in the medium.
The effect of RSCAH was tested by adding increasing volumes
(from 25 to 300 j.tl) of rinse solution concentrates in the reaction
chamber. The same measurements were performed in presence of
EGTA (1 x iO M).
Rinse solution concentrates from y ray-sterilized cellulose
acetate were tested under the same conditions as RSCAH. As a
control we also tested the action of rinse solution concentrates
from blood lines and 2 liters of sterile and apyrogenic water.
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Experiments were then done in presence of 100 l of RSCAH
and of various concentrations of Diltiazem (from 1 x i0 to 5 X
10—8 M), Bepridil (from 1 X i0 to 1 X i0 M), and Verapamil
(from 1 x iO to 5 x 10—6 M).
We finally studied the action of various amounts of Ca2 (15,
30, 50 nmoles in the reaction chamber) without RSCAH.
Calcium fluxes
A specific Ca2 electrode (Orion 9320) fitted to a Linseis
recorder via an SA720 Orion ionometer was used to record Ca2
movements in extramitochondrial medium in a thermostat-con-
trolled reaction chamber (3.8 ml) at 25°C containing the same
respiratory medium and succinate (final concentration, 6 mM).
The Ca2 concentration in extramitochondrial medium decreased
rapidly when mitochondria (2 mg of mitochondrial protein in the
reaction chamber) were added, because of uptake into mitochon-
dna. This was followed by a dynamic steady state resulting from
equilibrium between Ca2 entry and release. After all the oxygen
in the medium had been consumed, anaerobiosis led to a Ca2
release.
Steady state was studied in presence of 50 nmoles Ca2 in the
reaction chamber (pH 7.2). Steady state was modified by adding
various volumes (from 100 to 200 ILl) of RSCAH about three
minutes after the beginning of the equilibrium. As a control 200 .il
of a rinse solution concentrate from polysulfone were added
during the steady state. Similar experiments were done by succes-
sively adding 5 nmoles of Ruthenium Red and 125 p1 of RSCAH.
We then studied the action of 125 1il of RSCAH under the same
conditions when the medium contained Diltiazem (10—v M).
To test the effect of RSCAH on the duration of steady state, the
experiments were performed in presence of 100 nmoles of Ca2 in
the reaction chamber. The Ca2 concentration was higher to
improve the accuracy of recordings. RSCAH (from 50 to 200 p1)
was added in the reaction chamber before mitochondria were
added. Control was done in presence of an amount of Ca2 taking
into account the calcium brought by RSCAH. The 02 consump-
tion over time was recorded simultaneously.
Experiments were then done in the same conditions in presence
Mitochondria
Succinate
ADP
Fig. 1. Schematic representation of 02 consumption by mitochondria.
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RSCAH
Mt
V3 RC P/U
-
%
25 10.5 5.8 4.6 2.5 6.2 1.4
50 18.1 5.2 8.5 1.8 10.4 1.6
100 31.2 7.9 17.7 2.5 17.6 2.4
150 43.9 5.7 27.5 2.9 25.1 1.6
200 52.3 2.2 32.5 3.7 30.2 1.5
300 63.4 4.1 37.4 2.6 36.8 3.1
Cellular study
Cells from human colon adenocarcinoma cell line HT29-D4
were maintained in Dulbecco's modified Eagle's medium supple-
mented with 4.5 g glucose/liter, 0.1 M sodium pyruvate plus
L-glutamine, penicillin and streptomycin and 10% fetal bovine
serum [171.
Increasing volumes of RSCAH (from 50 to 200 i.tl) were added
in wells containing 2 x i0 HT29-D4 cells. The total volume was
200 .rl. The cytotoxicity and cell penetration of RSCAH were
assessed by the tetrazolium assay [181 as previously described
(MTT test) [17]. After 24 hours of incubation with RSCAH,
cytotoxicity and cell penetration were determined by measuring
the optical density (OD) of wells at 550 nm with using a Dynatech
MR 7000 apparatus. Controls were obtained in the same condi-
tions without RSCAH. Similar experiments were performed in
presence of 100 p1 of RSCAH and increasing concentrations of
Diltiazem (from 1 x 10—8 to 3 x 10—6 M).
Results are expressed as the percentage of dead cells.
Statistical analysis
The unpaired Student's t-test and linear regression analysis
were used. The null hypothesis was rejected at a value of P < 0.05
[19].
RESULTS
Action of RSCAH on oxidative phosphorylation
Rinse solution concentrates from blood lines and from sterile
and apyrogenic water had no effect on mitochondrial parameters
(data not shown).
RSCAH impaired V3, RC, and P/O in a dose-dependent
manner. Table 1 gives the experimental values in one series of
measurements as an example. Results from all the experiments,
expressed as percentages of alteration, are given in Table 2. The
data were treated by linear regression analysis. In the first
approximation the best relationship between V, the volume of
RSCAH tested, and E, the effect observed, was given by the
X 100 equation:
g 100- E = a1 g V + g K (Eq. 1)
where E is the observed effect expressed as percent, V is the
volume expressed in j.tl, a1 is slope value of the straight line, and
K = 1/(V))'. From the regression thus obtained, it was shown
Table 1. Alteration of mitochondrial respiration parameters by
RSCAH
RSCAH
j.d V3 RC PlO
0 121.6 3.47 1.23
25 108.2 3.33 1.17
50 97.9 3.18 1.09
100 84.0 2.83 1.02
150 70.5 2.44 0.91
200 56.8 2.31 0.84
300 47.2 2.13 0.78
Table 2. Alterations of mitochondrial respiration parameters by
RSCAH
Results are expressed as percentages of decrease. Each value represents
the mean SD of 6 to 12 measurements. After transformation of data
according to relationship (Eq. 1) given in the Results section, their
variations were significant (P < 0.001).
Values correspond to one series of experiments. V3 is expressed as
nmoles of O2/mg of mitochondrial protein/mm, RC is V3/V4, and P/O is
the number of ADP molecules phosphorylated per oxygen atom con-
sumed.
of 100 1.d of RSCAH and of various concentrations of Diltiazem
(from 1 X i09 to I X 10_6 M), Bepridil (from I X i0 to 5 X
io M), and Verapamil (from 5 x 108 to 1 x 1O M), which
were added in the medium just after RSCAH.
In all cases experiments were done in triplicate.
Other measurements
The inorganic phosphorus (P1) concentration in RSCAH was
measured by Hurst's method [16].
Calcium concentrations in mitochondrial respiratory medium
and RSCAH were determined by plasma atomic emission spec-
trometry (Jobin et Yvon JY24). We also determined the concen-
tration of several metals in RSCAH. Cadmium was measured
by atomic absorption spectrometry (Electrothermic Unicam
939QZ). Lead, nickel, chromium, copper were measured by
plasma emission atomic spectrometry (Jobin et Yvon, JY24).
Mercury was determined by fluorimetric measurements (PSA
Merlin Spectra, France) after nitric acid mineralization of
RSCAH.
Except for P1 and calcium the same determinations were also
done on a sample of fibers (1 g) detached from a cellulose acetate
hemodialyzer. Before measurement, the sample was mineralized
in glass tube with a microdigest (Prolabo A301) that combined a
nitric acid attack and focalized micro waves.
Expression of results
Alterations of the V3, P/U ratio, respiratory controls (RC), and
duration of steady state were expressed as percentages calculated
with reference to control values. Each value represents the
means so of at least six measurements.
Restoration of parameters by calcium channel blockers (CCB)
was calculated as follows:
% Restoration
(V3, PlO or SSD) (RSCAH + CCB) —
(V3,P/U or SSD) (RSCAH)
(V3. P/U or SSD) (control) —
(V3, P/U or SSD) (RSCAH)
where SSD is steady state duration and RSCAH is the rinse
solution concentrate from the cellulose acetate hemodialyzer.
Each value represents the means SD of at least six measure-
ments.
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Table 3. V10 values calculated for different membranes with regard to
their effect on V3, RC and P/O
Membranes
V50 jd
V5 RC PlO
Cellulose acetate ETO 187 22 422 55 531 58
Cellulose acetate -y rays 190 20 417 54 525 52
Polysulfone" 1120 145 1205 120 1425 112
Values for polysulfone were previously published [20]
Cellulose acetate membranes (ETO and y rays) did not differ signifi-
cantly.
the effect was significantly dose-dependent (P < 0.001). The
equation also allows the calculation of V50, which corresponds to
the volume of RSCAH that yields the half-maximal effect (EC50).
The V50 values allowed us to compare different membranes. Table
3 reports these values for V3, RC, and PlO in the case of RSCAH
and of rinse solution concentrates from ETO-sterilized polysul-
fone and y ray-sterilized cellulose acetate. The polysulfone results
have been already published [201.
An addition of EGTA (10—s at) in the respiratory medium
totally suppressed the effect of RSCAH (not shown).
The addition of 15 or 30 nmoles of calcium in the reaction
chamber did not significantly modify V5, RC, and PlO. With 50
nmoles an alteration of only about 5% was observed.
The Ca2 concentration in the respiratory medium was about
2 x 106 M.
Table 4 reports the results of the analysis of RSCAH for Ca2 ,
inorganic phosphorus (Pi), and heavy or other metals. The
analyses were done in three different RSCAI-I samples from the
three manufacturing batches of ETO-sterilized cellulose acetate
dialyzers.
The concentrations of metals measured directly on fibers
detached from a dialyzer after mineralization were less than
10_6 M.
Action of RSCAH on mitochondrial calcium fluxes
RSCAH added during the steady state induced a calcium
release followed by a partial re-entry (Fig. 2). An addition of 20
nmoles of Ca2 in the same conditions did not significantly modify
the steady state (Fig. 2 insert).
The rinse solution concentrates from polysulfone (200 pA) did
not induce a Ca2 release when added at the steady state under
the same conditions as for RSCAH (data not shown).
Figure 3A shows the effect of successive addition of Ruthenium
Red (5 nmoles) and RSCAH (125 pA) during the steady state.
Ruthenium Red induced a calcium release. RSCAH induced a
supplementary release not followed by a calcium re-entry.
RSCAH decreased the steady state duration in a dose-depen-
dent manner (Fig. 4). The recordings corresponded to a sample of
RSCAH containing 0.3 X i0 M Ca2, that is, 6 nmoles of Ca2
for 200 pA. For the control we thus added 6 supplementary nmoles
to the 100 nmoles of Ca2, which correspond to the highest
volume of RSCAH. Figure 4 also shows traces of simultaneous °2
consumption.
Corrective effect of calcium channel blockers
Table 5 shows the variation of restoration percentage of V3 and
PlO as a function of CCB concentrations for Diltiazem, Bepridil,
Table 4. Composition of three different samples of RSCAH
Samples
Ca2 Pi
Cd, Pb, Ni, Cr,
Cu, Hg
M
1 0.30 x iO 0.05 x i0 NS NS
2 0.95 x iO 0.05 x i0 NS NS
3 0.55 x iO 0.04 x i0 NS NS
Each value represent the mean so of 3 measurements. NS is not
significant.
and Verapamil. Depending on the doses, CCB had two effects: at
low concentrations they restored V3 and P/U near to their initial
values, and at higher concentrations they decreased them. For the
three drugs two equations of linear regresssion were obtained for
each parameter: V3, RC, and P/O. In the first approximation the
best relationship between E, the effect observed (% of restora-
tion), and C, the concentration of drugs was:
E = aLogC + b (Eq. 2)
One equation corresponding to the increase in restoration had a
positive regression coefficient (a), and the other equation corre-
sponding to the decrease in restoration had a negative one. From
the regression thus obtained it was shown that the two effects were
significantly dose-dependent (P < 0.05).
Table 6 reports the restoration percentage of SSD by Diltiazem,
Bepridil, and Verapamil. The maximal percentage of the restora-
tion of the duration of steady state ranged from 63% to 51% for
the three drugs and decreased at higher and lower concentrations
of all three drugs.
The data were treated by linear regression analysis and the
relationship between E (%of restoration) and C (concentration)
had the same form as equation 2. The two effects were signifi-
cantly dose-dependent (P < 0.05).
Diltiazem did not modify the RSCAH-induced Ca2 release
(Fig. 3B).
Cellular study
As we have previously shown, RSCAH was cytotoxic [20] and its
effect was dose dependent (Table 7). As above, the data were
treated by linear regression analysis and the relationship between
V and E was the same as for mitochondrial parameters (relation-
ship 1). The effect was significantly dose-dependent (P < 0.05).
Table 8 shows the variation of the percentage of cells killed by
100 p.1 of RSCAH as a function of Diltiazem concentrations. As
for restoration of V3, P/O and duration of steaty state Diltiazem
had two effects: at low concentrations it protected the cell in a
dose-dependent manner (the percentage of dead cells decreased)
but when the concentration became too high, the protective effect
decreased (the percentage of dead cells increased). The data were
treated by linear regression analysis, and the relationship between
E (% of dead cells) and C (concentration) had the same form as
in equation 2. The two effects were significantly dose-dependent
(P < 0.05).
DISCUSSION
The purpose of the present paper was to study the mechanism
of action of the rinse solution from a cellulose acetate hemodia-
lyzer (RSCAH) on mitochondria, and to determine if calcium
channel blockers (CCB) have a corrective effect and how they act.
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Fig. 2. Ca2 release induced by RSCAH added during the steady state
before anaerobiosis. Mitochondria: 2 mg of protein in the reaction
chamber. Ca2 added: 50 nmol in the reaction chamber. Arrows indicate
the addition of reagents. (a) Control; (b) 100 pA of RSCAH; (c) 150 /Ll of
RSCAH; (d) 200 pA of RSCAH. Insert. The effect of the addition of 20
nmo!es of Ca25 during the steady State.
Mechanism of action of RSCAH on isolated mitochondria
Rinse concentrates from blood lines or sterile and apyrogenic
water had no effect under our experimental conditions, thus
proving that our results are only due to the action of RSCAH.
Tables 1, 2 and 3 confirm our previous results [13, 20], and
clearly demonstrate that RSCAH exerts a decoupling effect on
isolated mitochondria, as shown by the decrease in respiratory
controls (RC; V50 = 422 55 j.d). The decoupling is predomi-
nantly due to a dose-dependent alteration of V3 (V5() = 187 22
jii). These data together with the concomitant decrease in PlO
ratio (V50 = 531 58 pA) indicate that RSCAH inhibits mito-
chondrial ATP synthesis.
These results were obtained in presence of Ca2 introduced in
the reaction chamber by reagents (about 4 nmoles) and by thc
RSCAH sample (from 5 to 30 nmoles at the most; Results).
Interestingly, all of the effects induced by RSCAH were totally
suppressed by the Ca25 chelating agent EGTA. The inhibition of
ATP synthesis is therefore a calcium-dependent phenomenom.
Hence, we studied the action of RSCAH on calcium fluxes
through mitochondrial membrane. After a mitochondrial calcium
overload, RSCAH induces a dose-dependent calcium release
from mitochondria when it was added during the steady state (Fig.
2). Theoretically the release may result from an increase in
calcium efflux, a decrease in influx, or both. Since the release is
followed by a calcium reentry (Fig. 2) it seems that RSCAH acts
at the level of efflux rather than influx mechanism. This assertion
is supported by experiments with Ruthenium Red (Fig. 3A). This
classical poison of mitochondrial calcium carrier breaks the
equilibrium between Ca2 uptake and release when added during
the steady state and thus induces a calcium release. However, it
did not affect the RSCAH-induced calcium efflux. Since the
carrier was blocked the Ca2 re-entry was suppressed. RSCAH
thus intervenes at the level of efflux, perhaps by acting on
mitochondrial membrane permeability transition [reviewed in 21]
and/or on mitochondrial NAD hydrolysis [221.
Calcium uptake is classicaly an alternative to oxidative phos-
phorylation, particularly in liver mitochondria [23, 241. Such an
uptake occurred in our experiments since the permanent
RSCAH-induced calcium release from mitochondrial stores was
followed by calcium reentry (Fig. 2), which requires a functional
mitochondrial calcium carrier. The permanent triggering of the
carrier thus established an energy-dissipating cyclic flux of calcium
across the mitochondrial membrane, thereby permanently bypass-
ing the phosphoiylated pathway. This thus explains the RSCAH-
induced decrease in V3 and P/O corresponding to an inhibition of
ATP synthesis.
RSCAH decreases the duration of steady state in a dose-
dependent manner (Fig. 4), proving that the ability of mitochon-
dna to Store calcium is diminished in the presence of RSCAH.
This finding is also supported by the fact that after the action of
RSCAH, the new steady State occurred at a higher level than
before the action (Fig. 2).
Two artifacts, however, could account for our results: the
presence of remaining ETO and/or Ca2 and metals brought by
the RSCAH samples.
(1.) ETO can be suspected since, despite extensive rinsing of
the dialyzers anaphylactic reactions due to ETO can be observed.
It is however possible to discard this possibility for two reasons.
(a) Rinse solution concentrates from ETO-sterilized blood lines
had no effect on mitochondria, proving that the three successive
lyophilizations correctly eliminated ETO. (b) Rinse solution con-
centrates from y ray-sterilized cellulose acetate dialyzer exhibited
the same mitochondrial toxicity as ETO-sterilized RSCAH, prov-
ing that the effects observed are due to cellulose acetate per se
(Table 3).(2.) Calcium can be also suspected, since a mitochondrial
calcium overload could induce effects identical to those we
observed. In this case also we can rule out such an action of
calcium because: (a) RSCAH contain at the most about iO M
Ca2, that is, 30 nmoles of Ca2 for 300 pA. The addition of 50
nmoles of Ca2 in the medium induces an alteration of only 5%
of V3 in absence of RSCAH (Results), whereas 300 j.d of RSAH
induced a 63.4% alteration (Table 2).
When added during the steady state, 200 pA of RSCAH lcd to
a marked release in calcium (Fig. 2). At the most the 200 pA
brought 20 nmoles of Ca25. Such a concentration did not trigger
a significant response of the calcium electrode (Fig. 2 insert).
Recordings of 02 consumption (Fig. 4) show that RSCAH
induced a dose-dependent increase in the 02 consumption rates.
The increase was always greater than those due to the uptake of
an identical amount of Ca2 .
Finally, RSCAH contains Pi, Cd, Pb, Ni, Cr, Cu, and Hg in
quantities too small to intervene in our experiments (Table 4).
Thus, it seems that the effects observed both on oxidative phos-
phorylation and calcium fluxes are due to the action of RSCAH
proper, that is, to substance(s) released from dialyzers during the
rinse.
Inhibition of ATP synthesis and modifications of calcium fluxes
Mitochondria
20 nmoles calcium
RSCAH
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Fig. 3. (A) Ca2 release induced by RSCAH
(150 s.d) in presence of Ruthenium Red (5
nmoles) added during the steady state before
anaerobiosis. Mitochondria: 2 mg of protein in
-* the reaction chamber. Ca2 added: 50 nmol in
the reaction chamber. (B) Recording in
presence of Diltiazem (10 M); arrows indicate
the addition of reagents.
Fig. 4. (A) Action of RSCAH on the duration of
steady state (SSD). Mitochondria: 2 mg protein
in the reaction chamber. Ca2 added: 100 nmoles
in the reaction chamber (Control was done in
Anaerobiosis presence of 106 nmoles of Ca2 in the reaction
chamber). Arrows indicate anaerobiosis. RSCAH
was added in the reaction chamber just before
mitochondria were added. (a) Control; (b) 75 jzl
of RSCAH; (c) 150 pJ of RSCAH; (d) 200 pA of
RSCAH. (B) Simultaneous 02 consumption re-
cordings.
extrusion pumps. Second, there would be a diminution of the
mitochondrial ability to store calcium. In vitro results showing an
increase in cytosolic calcium in several types of cells after contact
with cuprammonium membrane further support the existence of
this double mechanism [31. Moreover, even if it is always difficult
to correlate an in vitro effect with an in vivo action, our findings are
also consistent with the rise in cytosolic calcium observed in
neutrophils from patients dialyzed with a cellulosic membrane [51.
A B
I Mitochondria Mitochondria50
25
12.50
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50
25
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20tM02
2 4 6 8
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Mitochondria
Mitochondria
a
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were obtained with isolated liver mitochondria, but they probably
occur in cells other than hepatocytes. Indeed, in cells such as
hepatocytes and neutrophils, mitochondrial calcium fluxes are
driven by the same sodium-independent mechanism [reviewed in
25j. Therefore, our in vitro findings may occur in neutrophils, and
if so, they would lead to an increase in (Ca2) by a double
mechanism. First, there would be a diminution of the available
ATP pool and thus an impairment of the ATP-dependent Ca2
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.Concentrations
M
Diltiazem Bepridil Verapamil
%
1.0 >< 10 8.5 3.9 — —
5.0 x 10 17.8 6.7 — —
1.0 x 10 25.3 8.1 — —
5.0>< lO 36.4 3.2 — 9.6 7.2
1.0 x 10 63.4 4.7 12.3 4.3 16.4 4.1
5.0 x i0 31.1 4.6 29.8 3.1 29.4 7.6
1.0>< 10-6 22.3 5.7 47.2 2.9 51.4 4.7
5.0 >< i0' — 58.1 6.8 31.5 8.7
1.0 x 10 — 38.3 4.7 18.6 4.6
5.Ox 10 15.7 3.2
This assertion is supported by the results with polysulfone, which
does not modify the intracellular calcium concentration. Results
in Table 3 showed that rinse solution concentrates from a
polysulfone dialyzer exhibited only a mild toxicity on mitochon-
dna (V30 > 1000 pA for V3, and for RSCAH 187 pA). Moreover,
rinse solution concentrates from the polysulfone membrane that
were added during the steady state did not induce a mitochondrial
calcium release. Another explanation for the elevation of (Ca2)1
may thus be that another besides ones listed above, such as
secondary hyperparathyroidism [reviewed in 261 might be the
responsible cause.
As we did not completely analyze the RSCAH components it is
difficult to hypothezise about the factor(s) responsible for the
effect of RSCAH. Classically dialysate reagents, particularly heavy
and other metals, can induce the mitochondrial permeability
transition [reviewed in 27]. In RSCAH our results showed that
there were only negligible amounts of metals, particularly Hg2
But Hg2 has been reported to induce a mitochondrial calcium
release at 3 >< 10 M [28]. We thus performed analyses directly
on the cellulose acetate membrane after mineralization. The
results confirm that the amounts of metals in cellulose acetate
cannot interfere with our results. To explain our finding it is then
possible to consider mono- or polysaccharides, which were de-
scribed in rinses from hollow fiber dialyzers [29]. Clearly, further
studies (HPLC and mass spectroseopy, for example) should seek
to separate and identify the substance(s) contained in RSCAH
that would be responsible for the mitochondrial action.
Corrective effect of CCB on RSCAH-injured mitochondria
We previously showed that some CCB are able to restore ATP
synthesis in isolated calcium-injured mitochondria [14]. Since
RSCAH acts in a calcium dependent manner we studied the
action of Diltiazem, Verapamil, and Bepridil on RSCAH-injured
mitochondria. The CCB restored both V3 and PLO and thus ATP
synthesis (Table 5). The restorative effect first increased in a
dose-dependent manner with low concentrations and then
reached a maximum value, near 100% in the case of DTZ. The
drug concentrations corresponding to the maximum were: I )<
10—8, 1 X 10—6 and 5 X i0 M for Diltiazem, Bepridil and
Verapamil, respectively, that is, in the range of those in cells
during therapeutical use [30]. The decrease in the corrective effect
is probably due to the decoupling action described for high
concentrations of CCB [311 and is in accordance with our previous
results [14]. Moreover, CCB restored the duration of the steady
state that was altered by RSCAH near to its normal value (Table
6), and mitochondria recovered their ability to store calcium. In
Concentrations
M
Table 5. Restoration of V3 and PlO by calcium channel blockers in RSCAH-injured mitochondria
Diltiazem Bepridil
% %
V3 PlO V3 PLO V3 PLO
Verapamil
%
1.0 x 10 27.7 6.9 17.4 57
5.0 x 10 ' 52.0 3.5 52.3 9.3
7.5 i0 61.1 4.3 71.5 9.5
1.0 >< 10 8 84.5 7.6 99.5 6.3
2.5 >< 10-8 72.4 4.7 61.5 4.3
5.0 x 10 8 51.3 3.2 10.5 4.9
1.0 x i0- 9.3 2.1 4.7 3.8
2.5 >< i0 31.4 4.9 29.4 7.8
5.0 x 10 59.1 6.5 64.9 93
7.5 >< 10 66.2 6.1 68.7 8.1
1.0 >< 10—6 76.3 5.3 71.3 4.2
5.0 x 10 6 45.7 3.4 31.7 5.7
1.0 x l0- 13.5 3.2 17.1 1.9
27.1 3.4 37.4 6.5
58.7 4.7 54.1 4.2
80.5 5.6 65.1 4.7
67.5 4.2 47.5 6.4
34.1 3.2 25.1 3.5
11.1 1.9 10.5 2.9
Results are expressed as percentages of restoration. Each value represents the mean SD of 6 to 7 measurements. After transformation of data
according to relationship (Eq. 2) given in the Results section, their variations were significant (P < 0.05).
Table 6. Restoration of the duration of steady state by calcium channel
blockers in RSCAH-injured mitochondria Table 7. Percentages of killed cells as a function of volumes ofRSCAH
RSCAH j! Dead cells %
0 0
50 17±2
100 30±5
150 40±4
200 47±4
Each value represents the mean SD of 4 to 8 measurements. After
transformation of data according to relationship (Eq. 1) given in the
Results section, their variations were significant (P < 0.05).
Results are expressed as percentages of restoration. Each value repre-
sents the mean su of 6 to 7 measurements. After transformation of data
according to relationship (Eq. 2) given in the Results section, their
variations were significant (P < 0.05).
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Table 8. Percentage of cells killed by 100 pJ of RSCAH in presence of
various concentrations of Diltiazem
Diltiazem M Dead cells %
0 31±51x10 27±3
4><i0_8 24±66x10 21±4ixio 15±4
4x107 8±2ixio6 13±3
3 x iO 20 4
Each value represents the mean SD of 8 measurements. After
transformation of data according to relationship (Eq. 2) given in the
Results section, their variations were significant (P < 0.05).
this case the results could also be described in a bell-shaped curve.
At a therapeutically relevant concentration the drugs thus coun-
teract the two deleterious effects of RSCAH on mitochondria.
We previously showed that, under our experimental conditions,
CCB do not act at the level of mitochondrial calcium release [14].
The corrective effect of CCB on the deleterious action of RSCAH
on mitochondria does not seem to be related to an action on the
calcium release. This was confirmed by the results in Figure 3B.
Diltiazem does not modify the calcium release induced be
RSCAH. The beneficial effect of CCB thus originates from
another mechanism, probably as a direct action at the level of
mitochondrial ATP synthesis.
To strengthen our CCB findings on isolated mitochondria, we
studied the action of CCB on cells injured by RSCAH in culture.
As Diltiazem proved the most potent in the mitochondrial test we
limited our study to it. As previously shown [20], RSCAH is
cytotoxic in a dose-dependent manner (Table 7) and the V5() value
is about 210 j.tl. The principle of the 3-(4,5-dimethylthiazol-2-yl)-
2,5 diphenyl tetrazolium bromide (MIT) test is based on the
cleavage of the tetrazolium ring of MITby active niitochondria
[181. Therefore, the cytotoxicity of a compound is appreciated
through the remaining living mitochondria after the action of the
compound whose cytotoxicity is studied. The effect of RSCAH
probably occurs through its action on mitochondria.
This assertion is supported by our previous results obtained
with polysulfone [20]. Rinse solution concentrates from polysul-
fone, which are very mildly toxic for mitochondria, were inactive
on HT29-D4 cells under our experimental conditions. Our pro-
posal is also supported by data in Table 8 proving that Dilitiazem
at least partially counteracts the cytotoxicity of RSCAH. The
beneficial effect first increases with the concentration of Diliti-
azem, reaches a maximum, then decreases as for the protective
effect of dilitiazem on the injured isolated RSCAH mitochondria.
The concentration required for the maximum was higher in Table
8 than in Table 5 or 6 probably because in this case Dilitiazem
must go through the cell membrane and cytosol before reaching
mitochondria in the cell. Finally, it seems that Dilitiazem protects
the cell through the restoration of mitochondrial ATP synthesis.
As the efficient concentrations of CCB were therapeutically
relevant, one can therefore hypothesize that, in dialysis-injured
blood cells, CCB permit the cell to maintain a normal (Ca24 ) by
restoring the ATP pool and the mitochondrial calcium storage
capability. This hypothesis is consistent with previous results
showing that in vivo CCB restore the ATP content [32] and
suppress the rise in (Ca2) in leukocytes from patients undergo-
ing dialysis [5, 26]. Moreover, these findings might intervene in the
explanation of the CCB efficiency in cells such as neutrophils,
which do not have L-calcium channels.
In conclusion, this study shows that: (a) RSCAH inhibits ATP
synthesis in isolated mitochondria by triggering an energy-dissi-
pating Ca2' cycle; (b) RSCAH hinders the mitochondrial calcium
storage; and (c) CCB restore the mitochondrial ATP synthesis
and calcium storage in vitro and probably in the cell. These results
are consistent with in vivo findings and allow us to propose an
explanation of the efficiency of CCB without the intervention of
L-calcium channels.
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APPENDIX
Abbreviations are: ATP, adenosine triphosphate; CCB, calcium channel
blockers; MIT, 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bro-
mide; ETO, ethylene oxide; V3, consumption rate during state 3 corre-
sponding to the ATP synthesis; V4, consumption rate during state 4 that is
reached when all ADP is phosphorylated into ATP; P/O ratio, yield of
ATP synthesis calculated from oxygen consumption during state 3; RC,
respiratory controls; RSCAH, rinse solution concentrate from cellulose
acetate hemodialyzcr.
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